ScreenerHero

MLC Malin Corporation plc

ISE · IE · Healthcare · Drug Manufacturers - Specialty & Generic · malinplc.com
7.000EUR0.00%Mkt Cap: 32.92M $P/E: —

Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic a…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$57.82BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.64BUSDP/E 65.2
HLN
Haleon plc
$39.01BUSDP/E 18.1
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.48BUSDP/E 11.7
UTHR
United Therapeutics Corporation
$23.23BUSDP/E 19.4
VTRS
Viatris Inc.
$20.15BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.27BUSDP/E 111.6
NBIX
Neurocrine Biosciences, Inc.
$14.79BUSDP/E 21.3
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.23BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.40BUSDP/E 28.4
KRK
Krka, d. d.
$8.63BUSDP/E 19.3
AMRX
Amneal Pharmaceuticals, Inc.
$7.07BUSDP/E 41.4
ALKS
Alkermes plc
$6.99BUSDP/E 109.6
HIMS
Hims & Hers Health, Inc.
$6.88BUSD
LNTH
Lantheus Holdings, Inc.
$6.53BUSDP/E 24.2
KNSA
Kiniksa Pharmaceuticals International, plc
$5.93BUSDP/E 77.9
APTX
Apotex Health Corp.
$5.27BUSD

Key Statistics

Company
Market Cap32.92M USD
Enterprise Value18.96M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)0 USD
Revenue/Share—
Last Price7.000 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2
CountryIE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-58.33
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.79
EPS (TTM)0.00
EPS (Forward)-0.12
52W Range
6.8008% of range9.300
52W High9.300 EUR
52W Low6.800 EUR
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE0.00%
ROA0.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.41M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-3.01%
Net Debt-14.02M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio16.13
Quick Ratio16.13
Book Value/Sh8.90 EUR
Cash/Share2.98 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)15.50 EUR
Upside (mean)+121.4%
Target Range15.50 EUR – 15.50 EUR
# Analysts1
Ownership
Shares Out.4.33M
Float892.64K
Insiders34.96%
Institutions44.29%
Technical
SMA 507.009 (-0.1%)
SMA 2007.503 (-6.7%)
Beta0.42
S&P 52W Chg16.45%
Avg Vol (30d)13
Avg Vol (10d)7
Technical Indicators
RSI (14)47.5
MACD-0.0164
MACD Signal-0.0265
MACD Hist.+0.0101
BB Upper7.079 EUR
BB Middle6.990 EUR
BB Lower6.901 EUR
BB Width2.56%
ATR (14)0.0217 EUR
Vol Ratio (20d)0.00x